Treatment of acute exacerbations of interstitial lung diseases with corticosteroids: Evidence?
Respirology · 2024-09 · 29 (9) · 747-750
DOI: 10.1111/resp.14788 ↗At a glance
Editorial in Respirology, published online on 2024-07-03. Written by Chi F Hung and 1 co-authors. Institution: Department of Medicine, Center for Interstitial Lung Diseases, University of Washington, Seattle, Washington, USA. Major MEDLINE topics: Lung Diseases, Interstitial, Adrenal Cortex Hormones. Cited 10 times so far (Crossref); 15 references. The full text is freely available in PubMed Central. Funded by: NHLBI NIH HHS.
Abstract (original language)
See related article
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Medicine, Center for Interstitial Lung Diseases, University of Washington, Seattle, Washington, USA.
- Department of Laboratory Medicine and Pathology, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle, Washington, USA.
ORCID profiles: Ganesh Raghu
Funding
- NHLBI NIH HHS
Cite
APA
Hung, C. F., & Raghu, G. (2024). Treatment of acute exacerbations of interstitial lung diseases with corticosteroids: Evidence?. Respirology, 29(9), 747-750. https://doi.org/10.1111/resp.14788
Vancouver
Hung CF, Raghu G. Treatment of acute exacerbations of interstitial lung diseases with corticosteroids: Evidence?. Respirology. 2024;29(9):747-750. doi:10.1111/resp.14788
BibTeX
@article{Hung2024,
author = {Hung, Chi F and Raghu, Ganesh},
title = {Treatment of acute exacerbations of interstitial lung diseases with corticosteroids: Evidence?},
journal = {Respirology},
year = {2024},
volume = {29},
number = {9},
pages = {747--750},
doi = {10.1111/resp.14788}
}
EUVIMED